JPRN-UMIN000007103已完成2 期
Feasibility study of TC (docetaxel/cyclophosphamide) as neoadjuvant chemotherapy for primary breast cancer with negative HER2 - Neoadjuvant TC(docetaxel/cyclophosphamide) therapy for HER2 negative breast cancer
Kyushu Breast Cancer Study Group0 个研究点目标入组 36 人开始时间: 2012年1月20日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. Bilateral breast cancer 2. Male breast cancer 3. With active another cancer 4. History of other malignancies within the last 5 years except for adequately treated non-melanoma skin cancer or carcinoma in situ of the cervix 5. History of hypersensitivity reaction to any drugs which are to be used in this study 6. Uncontrolled underlying medical conditions 7. Patients who need concurrent treatment by corticosteroids except for premedication 8. Severe psychiatric disorders 9. Pregnant or lactation women, or women with suspected pregnancy 10. Patients judged by the investigator to be unfit to be enrolled into the study
研究者
相似试验
已完成
2 期
Feasibility study of TC(docetaxel+Cyclophosphamide)as adjuvant chemotherapy for intermediate risk primary breast cancer with HER2-negative and ER-positive tumor(KBC-SG 0803)Breast cancerJPRN-UMIN000001582Kyushu Breast Cancer Study Group102
已完成
2 期
Dose Dense TC + Pegfilgrastim Support for Breast CancerFemale Breast CancerNCT01671319University of Wisconsin, Madison42
未知
2 期
A Phase II study of docetaxel (T) and cyclophosphamide(C) as adjuvant chemotherapy for patients with high risk, node negative, early stage breast cancerBreast cancerJPRN-UMIN000000493Japan East Cancer Center Breast Cancer Consortium50
招募中
不适用
Feasibility study of combination Docetaxel, Cisplatin, and S-1 as neoadjuvant chemotherapy for advanced gastric cancer.gastric cancerJPRN-UMIN000005984Sapporo Medical University School of Medicine Dept. of Internal Medicine(4)20
已完成
不适用
A feasibility study of docetaxel + cisplatin + capecitabine (DCX) therapy for unresectable advanced gastric cancerGastric cancerJPRN-UMIN000006009Department of Gastroenterology, Nagoya University Graduate School of Medicine6